Clover Health Investments

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLOV and other ETFs, options, and stocks.

About CLOV

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. 

CEO
Andrew Toy
CEOAndrew Toy
Employees
570
Employees570
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2014
Founded2014
Employees
570
Employees570

CLOV Key Statistics

Market cap
1.36B
Market cap1.36B
Price-Earnings ratio
-24.27
Price-Earnings ratio-24.27
Dividend yield
Dividend yield
Average volume
5.76M
Average volume5.76M
High today
$2.88
High today$2.88
Low today
$2.61
Low today$2.61
Open price
$2.80
Open price$2.80
Volume
6.99M
Volume6.99M
52 Week high
$4.87
52 Week high$4.87
52 Week low
$2.12
52 Week low$2.12

Stock Snapshot

The current Clover Health Investments(CLOV) stock price is $2.65, with a market capitalization of 1.36B. The stock trades at a price-to-earnings (P/E) ratio of -24.27.

During the trading session on 2026-01-15, Clover Health Investments(CLOV) shares reached a daily high of $2.88 and a low of $2.61. At a current price of $2.65, the stock is +1.5% higher than the low and still -8.0% under the high.

Trading volume for Clover Health Investments(CLOV) stock has reached 6.99M, versus its average volume of 5.76M.

The stock's 52-week range extends from a low of $2.12 to a high of $4.87.

The stock's 52-week range extends from a low of $2.12 to a high of $4.87.

CLOV News

Simply Wall St 16h
Clover Health Is Up 12.4% After AI Platform Drives Top HEDIS Score, Fewer Hospitalizations

In early 2026, Counterpart Health, a subsidiary of Clover Health Investments, reported 2025 results showing wider clinician adoption of its AI-powered physician...

Clover Health Is Up 12.4% After AI Platform Drives Top HEDIS Score, Fewer Hospitalizations
Benzinga 1d
TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were lower, with the Nasdaq Composite falling more than 200 points on Wednesday. Shares of TG Therapeutics Inc (NASDAQ:TGTX) rose sharply during We...

TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday
TipRanks 1d
Clover Health Projects 2026 Profitability as Membership Surges

Claim 70% Off TipRanks Premium Clover Health Investments ( (CLOV) ) just unveiled an update. On December 16, 2025, Clover Health Investments announced that CE...

More CLOV News

TipRanks 1d
Clover Health announces 53% y/y membership growth in Medicare Advantage PPO

Clover Health (CLOV) Investments announced 53% year-over-year membership growth in its Medicare Advantage PPO plans for the 2026 plan year. Following this stron...

Nasdaq 3d
Outset Medical Soars 22.2%: Is Further Upside Left in the Stock?

Outset Medical, Inc. OM shares ended the last trading session 22.2% higher at $5.57. The jump came on an impressive volume with a higher-than-average number of...

Outset Medical Soars 22.2%: Is Further Upside Left in the Stock?
Simply Wall St 6d
Assessing Clover Health Investments Valuation After CEO Insider Share Sale Pattern

On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider sellin...

Assessing Clover Health Investments Valuation After CEO Insider Share Sale Pattern

People also own

Based on the portfolios of people who own CLOV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .